Psychotic Disorders - Fiji | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$468.20k in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -2.36%, resulting in a market volume of US$415.60k by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$84.15 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Fiji is experiencing steady growth due to various factors. Customer preferences for effective treatment options and increased awareness about mental health are driving the demand for psychotic disorder medications. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the development of the market.

Customer preferences: Customers in Fiji have shown a growing preference for effective treatment options for psychotic disorders. As awareness about mental health issues increases, individuals are seeking appropriate medications to manage their symptoms. This has led to a rise in demand for antipsychotic drugs and other treatment options. Customers are also increasingly looking for medications that have minimal side effects and can be easily accessed.

Trends in the market: One of the key trends in the Psychotic Disorders market in Fiji is the growing use of antipsychotic medications. These drugs are widely prescribed by healthcare professionals to manage symptoms such as hallucinations, delusions, and disorganized thinking. The market is also witnessing an increase in the use of psychosocial interventions, such as cognitive-behavioral therapy, to complement medication-based treatments. This trend reflects the holistic approach towards treating psychotic disorders and the recognition of the importance of therapy in conjunction with medication.

Local special circumstances: Fiji, like many other countries, faces unique challenges when it comes to mental health. Limited access to healthcare facilities and a shortage of mental health professionals are some of the local special circumstances that impact the Psychotic Disorders market. These circumstances highlight the need for effective and accessible treatment options that can be easily administered in community settings. Additionally, cultural beliefs and stigma surrounding mental health may influence customer preferences and the utilization of available treatment options.

Underlying macroeconomic factors: The development of the Psychotic Disorders market in Fiji is also influenced by underlying macroeconomic factors. Economic growth and increased healthcare spending are contributing to the availability of resources for mental health services. As the economy improves, individuals have greater access to healthcare facilities and medications. Furthermore, government initiatives and policies aimed at improving mental health services are also driving the growth of the market.In conclusion, the Psychotic Disorders market in Fiji is developing due to customer preferences for effective treatment options, increased awareness about mental health, local special circumstances, and underlying macroeconomic factors. The market is witnessing a growing demand for antipsychotic medications and psychosocial interventions. However, challenges such as limited access to healthcare facilities and cultural stigma surrounding mental health need to be addressed to ensure the continued growth and development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.